| |
| |
|
| Insider
Information: |
Day Wesley |
| Relationship: |
VP, Clinical Development |
| City: |
Mountain View |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
49,118 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,766 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
49,118 |
|
|
| Total
Value |
$5,766 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vivus Inc |
VVUS |
VP, Clinical Development |
2015-07-01 |
49,118 |
2006-03-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VVUS |
Vivus Inc |
VP, Clinical Development |
• – – |
2015-07-01 |
4 |
S |
$2.32 |
$18,284 |
D/D |
(7,881) |
49,118 |
0 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Development |
• – – |
2015-01-29 |
4 |
S |
$2.78 |
$1,312 |
D/D |
(472) |
56,999 |
0 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Development |
• – – |
2015-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
24,500 |
57,471 |
0 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Development |
• – – |
2015-01-01 |
4/A |
S |
$3.04 |
$7,749 |
D/D |
(2,549) |
46,569 |
0 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Development |
• – – |
2014-07-02 |
4 |
D |
$5.31 |
$12,112 |
D/D |
(2,281) |
32,971 |
0 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Development |
• – – |
2014-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
4,200 |
35,252 |
0 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Development |
• – – |
2014-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
31,052 |
0 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Research |
• – – |
2012-07-18 |
4 |
AS |
$30.36 |
$510,048 |
D/D |
(16,800) |
0 |
0 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Development |
• – – |
2012-02-23 |
4 |
AS |
$20.69 |
$1,654,331 |
D/D |
(79,958) |
16,800 |
0 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Development |
• – – |
2012-02-23 |
4 |
OE |
$3.28 |
$330,162 |
D/D |
79,958 |
67,062 |
0 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Development |
• – – |
2012-01-09 |
4 |
AS |
$11.50 |
$345,000 |
D/D |
(30,000) |
16,800 |
0 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Development |
• – – |
2012-01-09 |
4 |
OE |
$3.28 |
$98,400 |
D/D |
30,000 |
46,800 |
0 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Development |
• – – |
2011-11-11 |
4 |
S |
$9.87 |
$231,349 |
D/D |
(23,442) |
16,800 |
0 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Development |
• – – |
2011-11-11 |
4 |
OE |
$3.13 |
$76,380 |
D/D |
23,442 |
40,242 |
0 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Development |
• – – |
2010-12-17 |
4 |
OE |
$3.26 |
$195,600 |
D/D |
60,000 |
87,400 |
0 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Development |
• – – |
2010-12-17 |
4 |
S |
$9.54 |
$635,491 |
D/D |
(66,600) |
20,800 |
0 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Development |
• – – |
2010-12-17 |
4/A |
S |
$9.54 |
$673,446 |
D/D |
(70,600) |
16,800 |
0 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Research |
• – – |
2008-05-14 |
4 |
B |
$4.17 |
$13,760 |
D/D |
3,297 |
16,843 |
2.74 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Research |
• – – |
2007-11-14 |
4 |
B |
$4.23 |
$13,139 |
D/D |
3,104 |
13,546 |
2.74 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Research |
• – – |
2007-05-14 |
4 |
B |
$3.06 |
$12,987 |
D/D |
4,244 |
10,442 |
2.74 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Research |
• – – |
2006-11-14 |
4 |
B |
$2.99 |
$6,576 |
D/D |
2,198 |
6,198 |
2.74 |
- |
|
| VVUS |
Vivus Inc |
VP, Clinical Research |
• – – |
2006-03-02 |
4 |
B |
$3.40 |
$13,600 |
D/D |
4,000 |
4,000 |
2.74 |
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
